New PET scan dye for lung cancer before surgery
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a new PET scan dye (called 18F-Alfatide) that might help doctors see lung cancer and its spread more clearly before surgery. If it works, it could make sure surgery removes all the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have or are suspected to have non-small cell lung cancer, and your doctor plans surgery to remove it and check nearby lymph nodes.
- You feel well enough for daily activities and can care for yourself (performance status score 0 or 1).
- Your kidneys work well (no significant kidney disease) and your fasting blood sugar is not too high (under 7.0 mmol/L).
- You have no allergies to the study injection or to FDG, and you are not pregnant or breastfeeding.
- You can tolerate a PET scan (no severe claustrophobia or fear of radiation).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a single dose of a special dye (LS301-IT) that helps surgeons see lung cancer cells more clearly during surgery. It aims to make lung cancer removal more precise and complete.
This study tests a new imaging dye (called a probe) that targets a specific change in lung cancer cells (EGFR mutation). The PET/CT scan uses this dye to see if the tumor can be clearly seen, which might help doctors plan better treatment.
This trial tests a new type of PET scan that uses a special tracer to find lung tumors. The goal is to see if this scan can better detect cancer cells, which may help doctors plan the best treatment for you.
This trial tests a newer PET/CT scan method to detect uncertain (indeterminate) lung nodules more accurately before biopsy or surgery. If you have a small lung nodule that doctors are still unsure about, this could help improve how nodules are found and assessed.
This study tests a new imaging agent that helps PET scans show cancer more clearly. It may help doctors see where cancer is in your body and plan your treatment better.
This study tests whether a special imaging scan using a radioactive sugar (18F-FDG) can help doctors better examine lung cancer tissue during thoracic surgery. You may be offered the scan around the time of your operation to help researchers learn how well it works.
Hear when a new Non-Small Cell Lung Cancer NSCLC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.